nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
|
Bron, Morgan |
|
2014 |
5 |
2 |
p. 521-534 |
artikel |
2 |
A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus
|
Domeki, Nozomi |
|
2014 |
5 |
2 |
p. 403-413 |
artikel |
3 |
A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes
|
Dailey, George |
|
2014 |
5 |
2 |
p. 385-402 |
artikel |
4 |
Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
|
Bennett, Hayley |
|
2014 |
5 |
2 |
p. 567-578 |
artikel |
5 |
Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
|
Bennett, Hayley |
|
|
5 |
2 |
p. 567-578 |
artikel |
6 |
Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?
|
Strain, William David |
|
2014 |
5 |
2 |
p. 347-354 |
artikel |
7 |
Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden
|
Kiadaliri, Aliasghar A. |
|
2014 |
5 |
2 |
p. 591-607 |
artikel |
8 |
Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study
|
Kaku, Kohei |
|
2014 |
5 |
2 |
p. 415-433 |
artikel |
9 |
Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data
|
Kamenov, Zdravko |
|
2014 |
5 |
2 |
p. 483-498 |
artikel |
10 |
Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study
|
Darpo, Borje |
|
2014 |
5 |
2 |
p. 609 |
artikel |
11 |
Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
|
Divino, Victoria |
|
2014 |
5 |
2 |
p. 499-520 |
artikel |
12 |
Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
|
Ahrén, Bo |
|
2014 |
5 |
2 |
p. 459-469 |
artikel |
13 |
Improving Self-Monitoring of Blood Glucose among Adults with Type 1 Diabetes: Results of the Mobile™ Study
|
Overland, Jane |
|
2014 |
5 |
2 |
p. 557-565 |
artikel |
14 |
Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes
|
Sreenan, Seamus |
|
2014 |
5 |
2 |
p. 447-458 |
artikel |
15 |
Initial Experience and Evaluation of Reusable Insulin Pen Devices Among Patients with Diabetes in Emerging Countries
|
Tschiedel, Balduino |
|
2014 |
5 |
2 |
p. 545-555 |
artikel |
16 |
Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
|
Vora, Jiten |
|
2014 |
5 |
2 |
p. 435-446 |
artikel |
17 |
Patient Characteristics are not Associated with Clinically Important Differential Response to Dapagliflozin: a Staged Analysis of Phase 3 Data
|
Bujac, Sarah |
|
2014 |
5 |
2 |
p. 471-482 |
artikel |
18 |
Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
|
Li, Qian |
|
2014 |
5 |
2 |
p. 579-590 |
artikel |
19 |
Role of Comorbidities as Limiting Factors to the Effect of Hyperbaric Oxygen in Diabetic Foot Patients: A Retrospective Analysis
|
Akgül, Esra A. |
|
2014 |
5 |
2 |
p. 535-544 |
artikel |
20 |
Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
|
Kalra, Sanjay |
|
2014 |
5 |
2 |
p. 355-366 |
artikel |
21 |
The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist
|
Bain, Stephen C. |
|
2014 |
5 |
2 |
p. 367-383 |
artikel |